Health | Page 34 of 43

Diabetic Retinopathy May Be Prevented By Statins

A statin drug (Lipitor) may help prevent blindness in people with diabetes, according to researchers at the University of Georgia College of Pharmacy. In a study using diabetic rats and isolated retinal cells cultured in high glucose, lead author Azza El-Remessy, assistant professor in the University of Georgia College of Pharmacy...

Robotic Drug May Prove a Good Treatment for Diabetic Foot Ulcers

Harvard University and Hebrew University scientists have developed a low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns. Several proteins, called growth factors, have been found to speed up the healing process, however purifying these growth factor proteins is very expensive, and they do not last long on the injured site....

Carbohydrate Cravings, Serotonin and Satiety

The dependence of serotonin synthesis on carbohydrate consumption and insulin poses a problem for diabetics...

Diabetes As Renewal: An Interview With Constance Brown-Riggs

I look at a diagnosis of diabetes, particularly type 2 diabetes, as a point of renewal...

Persistence and Power: An Interview with Diabetic Powerlifter Ginger Vieira

Trying to balance my blood sugar on a competition day is the hardest part...

Piloxing, Weighted Vests, Fitbit and Other 2011 Fitness Trends

Wearing weighted vests turns a simple walk into a strength training workout...

Diabetes Epidemic in the Middle East

The New York Times reported on the rapidly growing diabetes epidemic in the Middle East and North Africa and the financial burden of health care costs to the region’s governments. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. They include the United Arab Emirates, showing the second-highest rate in the world — behind only the tiny Pacific island state of Nauru — followed by Bahrain, Egypt, Kuwait, Oman and Saudi Arabia...

Novartis Drug Lucentis Approved by EU Commission for Treatment of Diabetic Macular Edema

The European Commission has granted Novartis a new indication for Lucentis (ranibizumab) to treat patients with visual impairment due to diabetic macular edema (DME) following two Novartis-sponsored clinical trials, RESTORE and RESOLVE. The trials showed that Lucentis was superior in providing rapid and sustained visual acuity gain versus placebo therapy or laser therapy..

Diabetes in The Next Decade: Predictions

In the last decade the number of diabetics jumped from 8% of the adult population to 12.3%. And things don't look like they're getting any better...

Healing Diabetic Foot Ulcers: Regenerative Medicine, Dermagraft, and Heal2gether

Dermagraft is an advanced wound care product that contains living human skin cells...